Dimensional Fund Advisors LP boosted its holdings in Xencor, Inc. (NASDAQ: XNCR) by 3.6% during the

Xencor (XNCR) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate

PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical co

PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR) (“Xencor”), a clinical-stage biopharma

U.S. stocks saw mixed results, with Nasdaq up 150 points. AMC shares rose after beating earnings exp

Xencor (XNCR) saw its shares surge in the last session with trading volume being higher than average

PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical co

Xencor, Inc. is shifting from licensing optionality toward a broader portfolio of in-house assets ac

MindWalk Holdings Corp. (NASDAQ: HYFT) today released a systematic report identifying over 20 discov

Xencor, Inc. (XNCR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Xencor (XNCR) came out with a quarterly loss of $1.71 per share versus the Zacks Consensus Estimate

PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical co

Xencor, Inc. (XNCR) Discusses Phase I Results for XmAb942 and Preclinical Data for XmAb412 Transcrip

PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical co

Xencor, Inc. (NASDAQ: XNCR - Get Free Report) passed below its 200-day moving average during trading

Top Wall Street analysts changed outlook on top names. See analyst rating changes, including upgrade

Pre-Market Stock Futures: After a volatile start to the week, futures are trading lower on Tuesday.

Xencor, Inc. (XNCR) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Xencor, Inc. (NASDAQ: XNCR - Get Free Report) has been given a consensus recommendation of "Moderate

Xencor, Inc. (NASDAQ: XNCR - Get Free Report)'s stock price gapped down before the market opened on

On Wednesday, Xencor Inc. (NASDAQ: XNCR) said it is revising its revenue outlook for royalties tied

PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical co

https://news.bloomberglaw.com/health-law-and-business/fda-names-vinay-prasad-as-new-head-of-vaccines

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly los

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

  On Wednesday, 311 stocks hit new 52-week lows.

  On Tuesday, 647 companies set new 52-week lows.

  On Monday, 369 companies set new 52-week lows.

  During the session on Thursday, 461 stocks hit new 52-week lows.

  During Tuesday's session, 275 companies made new 52-week lows.

  Friday's session saw 225 companies set new 52-week lows.

  On Wednesday, 179 companies reached new 52-week lows.

  On Tuesday, 164 companies achieved new lows for the year.

  During Thursday's session, 92 stocks hit new 52-week lows.

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 pe

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnin

Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quar

  Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report qua

  During Monday's trading, 1214 companies set new 52-week lows.

  During the Thursday's session, 100 stocks hit new 52-week lows.

  On Wednesday, 73 stocks hit new 52-week lows.

  Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report

  During Wednesday's trading, 435 companies set new 52-week lows.

  During Thursday, 849 stocks hit new 52-week lows.

  During Tuesday's session, 454 stocks hit new 52-week lows.